title: Tylenol-Maker Kenvue’s Stock Is Down 30% in 2025. Its Fate May Be in the FDA’s Hands.
source: Yahoo
date: 2025-10-22
url: https://finnhub.io/api/news?id=1a01fcbc54ea2c680fa8078769b2a5a08b277779cba308bf10952f321054192c
The former consumer health unit of Johnson & Johnson remains mired in troubles surrounding Tylenol.
